Literature DB >> 29924988

Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia.

Michael B Ryan1, Chloe Bair-Marshall2, Alexandra B Nelson3.   

Abstract

Action selection relies on the coordinated activity of striatal direct and indirect pathway medium spiny neurons (dMSNs and iMSNs, respectively). Loss of dopamine in Parkinson's disease is thought to disrupt this balance. While dopamine replacement with levodopa may restore normal function, the development of involuntary movements (levodopa-induced dyskinesia [LID]) limits therapy. How chronic dopamine loss and replacement with levodopa modulate the firing of identified MSNs in behaving animals is unknown. Using optogenetically labeled striatal single-unit recordings, we assess circuit dysfunction in parkinsonism and LID. Counter to current models, we found that following dopamine depletion, iMSN firing was elevated only during periods of immobility, while dMSN firing was dramatically and persistently reduced. Most notably, we identified a subpopulation of dMSNs with abnormally high levodopa-evoked firing rates, which correlated specifically with dyskinesia. These findings provide key insights into the circuit mechanisms underlying parkinsonism and LID, with implications for developing targeted therapies.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease; basal ganglia; dopamine; dyskinesia; electrophysiology; levodopa; optogenetics; striatum

Mesh:

Substances:

Year:  2018        PMID: 29924988      PMCID: PMC6407866          DOI: 10.1016/j.celrep.2018.05.059

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  50 in total

1.  Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum.

Authors:  S N Haber; J L Fudge; N R McFarland
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias.

Authors:  S M Papa; R Desimone; M Fiorani; E H Oldfield
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

3.  Dopamine Depletion Impairs Bilateral Sensory Processing in the Striatum in a Pathway-Dependent Manner.

Authors:  Maya Ketzef; Giada Spigolon; Yvonne Johansson; Alessandra Bonito-Oliva; Gilberto Fisone; Gilad Silberberg
Journal:  Neuron       Date:  2017-05-17       Impact factor: 17.173

4.  The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain.

Authors:  A J McGeorge; R L Faull
Journal:  Brain Res       Date:  1987-10-13       Impact factor: 3.252

Review 5.  Primate models of movement disorders of basal ganglia origin.

Authors:  M R DeLong
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

6.  Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy.

Authors:  Cristina Alcacer; Laura Andreoli; Irene Sebastianutto; Johan Jakobsson; Tim Fieblinger; Maria Angela Cenci
Journal:  J Clin Invest       Date:  2017-01-23       Impact factor: 14.808

7.  Selective activation of striatal fast-spiking interneurons during choice execution.

Authors:  Gregory J Gage; Colin R Stoetzner; Alexander B Wiltschko; Joshua D Berke
Journal:  Neuron       Date:  2010-08-12       Impact factor: 17.173

8.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

9.  GENSAT BAC cre-recombinase driver lines to study the functional organization of cerebral cortical and basal ganglia circuits.

Authors:  Charles R Gerfen; Ronald Paletzki; Nathaniel Heintz
Journal:  Neuron       Date:  2013-12-18       Impact factor: 17.173

10.  Concurrent activation of striatal direct and indirect pathways during action initiation.

Authors:  Guohong Cui; Sang Beom Jun; Xin Jin; Michael D Pham; Steven S Vogel; David M Lovinger; Rui M Costa
Journal:  Nature       Date:  2013-01-23       Impact factor: 49.962

View more
  33 in total

Review 1.  Dopaminergic modulation of striatal function and Parkinson's disease.

Authors:  Shenyu Zhai; Weixing Shen; Steven M Graves; D James Surmeier
Journal:  J Neural Transm (Vienna)       Date:  2019-04-01       Impact factor: 3.575

2.  Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson's disease.

Authors:  Ettel Keifman; Irene Ruiz-DeDiego; Diego Esteban Pafundo; Rodrigo Manuel Paz; Oscar Solís; Mario Gustavo Murer; Rosario Moratalla
Journal:  Br J Pharmacol       Date:  2019-05-21       Impact factor: 8.739

3.  Striatal Direct Pathway Targets Npas1+ Pallidal Neurons.

Authors:  Qiaoling Cui; Xixun Du; Isaac Y M Chang; Arin Pamukcu; Varoth Lilascharoen; Brianna L Berceau; Daniela García; Darius Hong; Uree Chon; Ahana Narayanan; Yongsoo Kim; Byung Kook Lim; C Savio Chan
Journal:  J Neurosci       Date:  2021-03-17       Impact factor: 6.167

4.  Abnormal Cortico-Basal Ganglia Neurotransmission in a Mouse Model of l-DOPA-Induced Dyskinesia.

Authors:  Indriani Dwi Wahyu; Satomi Chiken; Taku Hasegawa; Hiromi Sano; Atsushi Nambu
Journal:  J Neurosci       Date:  2021-02-09       Impact factor: 6.167

5.  Striatal Kir2 K+ channel inhibition mediates the antidyskinetic effects of amantadine.

Authors:  Weixing Shen; Wenjie Ren; Shenyu Zhai; Ben Yang; Carlos G Vanoye; Ananya Mitra; Alfred L George; D James Surmeier
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

6.  Dysregulation of external globus pallidus-subthalamic nucleus network dynamics in parkinsonian mice during cortical slow-wave activity and activation.

Authors:  Ryan F Kovaleski; Joshua W Callahan; Marine Chazalon; David L Wokosin; Jérôme Baufreton; Mark D Bevan
Journal:  J Physiol       Date:  2020-04-23       Impact factor: 5.182

Review 7.  Aberrant features of in vivo striatal dynamics in Parkinson's disease.

Authors:  Kwang Lee; Sotiris C Masmanidis
Journal:  J Neurosci Res       Date:  2019-09-09       Impact factor: 4.164

8.  Translating Insights From Optogenetics To Therapies For Parkinson's Disease.

Authors:  Aryn H Gittis; Eric A Yttri
Journal:  Curr Opin Biomed Eng       Date:  2018-09-12

Review 9.  A competitive model for striatal action selection.

Authors:  S Bariselli; W C Fobbs; M C Creed; A V Kravitz
Journal:  Brain Res       Date:  2018-10-06       Impact factor: 3.252

10.  Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.

Authors:  Rhyomi C Sellnow; Kathy Steece-Collier; Feras Altwal; Ivette M Sandoval; Jeffrey H Kordower; Timothy J Collier; Caryl E Sortwell; Anthony R West; Fredric P Manfredsson
Journal:  J Neurosci       Date:  2020-04-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.